| Aug 22 |
This Undervalued Stock Could Join the Race With Eli Lilly to the $1 Trillion Club
|
| Aug 21 |
Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know
|
| Aug 21 |
J&J (JNJ) Gets FDA Nod for Chemotherapy-Free Lung Cancer Therapy
|
| Aug 21 |
J&J (JNJ) to Boost MedTech Business With V-Wave Acquisition
|
| Aug 21 |
Covid-19: vaccine pricing varies wildly by country and company
|
| Aug 20 |
J&J Gets FDA Approval of New Chemo-Free Lung Cancer Treatment
|
| Aug 20 |
Johnson & Johnson to Acquire V-Wave for $1.1 Billion
|
| Aug 20 |
FTC says FDA biosimilar guidance would increase competition, lead to lower prices
|
| Aug 20 |
Top Midday Stories: Lowe's Cuts EPS, Revenue Guidance; Johnson & Johnson to Buy V-Wave for Up to $1.7 Billion
|
| Aug 20 |
Johnson & Johnson Agrees to Acquire Heart-Tech Firm V-Wave For up to $1.7 Billion
|
